✦ LIBER ✦

Effect of statins on outcomes in immunosuppressed patients with bloodstream infection

✍ Scribed by D. Viasus; C. Gudiol; N. Fernández-Sabé; I. Cabello; C. Garcia-Vidal; M. Cisnal; R. Duarte; M. Antonio; J. Carratalà

Publisher: Springer
Year: 2010
Tongue: English
Weight: 127 KB
Volume: 30
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-010-1056-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statins are associated with improved out

Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients

✍ J. Hsu; D. R. Andes; V. Knasinski; J. Pirsch; N. Safdar 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 142 KB

Sources and outcome of bloodstream infec

Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters

✍ I. Raad; R. Hachem; H. Hanna; P. Bahna; I. Chatzinikolaou; X. Fang; Y. Jiang; R. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 156 KB

Rates of hospital-acquired bloodstream i

Rates of hospital-acquired bloodstream infections in patients with specific malignancy

✍ James W. Mayo; Richard P. Wenzel 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

Prospective evaluation of the epidemiolo

Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients

✍ E. Velasco; M. Soares; R. Byington; C. A. S. Martins; M. Schirmer; L. M. C. Dias 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 108 KB

Effect of Perioperative Immunosuppressiv

Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients

✍ Adrian A. Indar; Tonia M. Young-Fadok; Jacques Heppell; Jonathan E. Efron 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 154 KB

Beta-blockers have no effect on outcomes

Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections

✍ Arnaud Galbois; Vincent Das; Dominique Thabut; Eric Maury; Hafid Ait-Oufella; Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6